Marcos Arango

750 total citations
25 papers, 502 citations indexed

About

Marcos Arango is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Marcos Arango has authored 25 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Epidemiology and 9 papers in Hematology. Recurrent topics in Marcos Arango's work include Fungal Infections and Studies (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Antifungal resistance and susceptibility (6 papers). Marcos Arango is often cited by papers focused on Fungal Infections and Studies (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Antifungal resistance and susceptibility (6 papers). Marcos Arango collaborates with scholars based in Colombia, Spain and United States. Marcos Arango's co-authors include Ángela Restrepo, Ángela Restrepo, Lynne Sigler, Carlos A. Agudelo, Luz Elena Cano, Ángela María Tobón, Catalina de Bedout, Yarzábal La, Olivia S. Anderson and Nicolás Bianco and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Plant Disease.

In The Last Decade

Marcos Arango

24 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos Arango Colombia 14 236 199 120 95 71 25 502
J C Voltarelli Brazil 11 401 1.7× 230 1.2× 59 0.5× 54 0.6× 145 2.0× 20 631
Zoe Dorothea Pana Greece 10 332 1.4× 311 1.6× 29 0.2× 34 0.4× 53 0.7× 14 500
Daniel Teschner Germany 14 177 0.8× 130 0.7× 143 1.2× 75 0.8× 223 3.1× 37 533
R.I. Schiff United States 8 524 2.2× 465 2.3× 91 0.8× 147 1.5× 299 4.2× 19 888
Hisashi FUNADA Japan 11 113 0.5× 141 0.7× 60 0.5× 24 0.3× 47 0.7× 56 412
Martha C. Moreno‐Lafont Mexico 14 101 0.4× 44 0.2× 81 0.7× 63 0.7× 279 3.9× 35 521
Elena B. Lugli United Kingdom 13 290 1.2× 121 0.6× 32 0.3× 12 0.1× 110 1.5× 22 736
Amado Saúl Mexico 20 710 3.0× 334 1.7× 21 0.2× 38 0.4× 48 0.7× 41 1.0k
Khaled Khoufache France 11 147 0.6× 163 0.8× 17 0.1× 57 0.6× 189 2.7× 13 489
Sivan Bercovici United States 13 183 0.8× 110 0.6× 39 0.3× 19 0.2× 17 0.2× 35 562

Countries citing papers authored by Marcos Arango

Since Specialization
Citations

This map shows the geographic impact of Marcos Arango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Arango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Arango more than expected).

Fields of papers citing papers by Marcos Arango

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Arango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Arango. The network helps show where Marcos Arango may publish in the future.

Co-authorship network of co-authors of Marcos Arango

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Arango. A scholar is included among the top collaborators of Marcos Arango based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Arango. Marcos Arango is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Orville C., Marcos Arango, Barnaby Thwaites, et al.. (2024). 194P Monitoring for pneumonitis due to trastuzumab deruxtecan (T-DXd): A single centre experience. ESMO Open. 9. 103216–103216.
2.
Abboud, Ramzi, Fei Wan, Jacopo Mariotti, et al.. (2021). Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplantation. 56(11). 2763–2770. 25 indexed citations
3.
Arango, Marcos, et al.. (2020). Measurable Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Adult Acute Lymphoblastic Leukemia in Colombia. Clinical Lymphoma Myeloma & Leukemia. 21(4). e365–e372. 3 indexed citations
4.
Arango, Marcos & Doris Cardona Arango. (2020). Hemorrhagic Cystitis after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Protective Effect of MESNA Continuous Infusion. Biology of Blood and Marrow Transplantation. 26(8). 1492–1496. 16 indexed citations
5.
Arango, Marcos, et al.. (2017). Fever after peripheral blood stem cell infusion in haploidentical transplantation with post-transplant cyclophosphamide. Hematology/Oncology and Stem Cell Therapy. 10(2). 79–84. 15 indexed citations
6.
Arango, Marcos, et al.. (2017). Cost–effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities. European Journal Of Haematology. 100(2). 140–146. 7 indexed citations
7.
8.
Arango, Marcos, et al.. (2015). General features and epidemiology of lymphoma in Colombia. A multicentric study. Annals of Hematology. 94(6). 975–980. 4 indexed citations
9.
Sanz, Jaime, Isabel Cano, Eva M. González‐Barberá, et al.. (2015). Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen. Biology of Blood and Marrow Transplantation. 21(4). 755–760. 26 indexed citations
10.
Arango, Marcos, et al.. (2015). Adult T-cell leukemia/lymphoma. Blood. 126(20). 2343–2343. 1 indexed citations
11.
Pino, Luís, et al.. (2014). C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms. Supportive Care in Cancer. 23(4). 1009–1013. 13 indexed citations
12.
Sanz, Jaime, Marcos Arango, Nelly Carpio, et al.. (2014). Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience. Bone Marrow Transplantation. 49(8). 1084–1088. 28 indexed citations
13.
Sanz, Jaime, Marcos Arango, Leonor Senent, et al.. (2013). EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases. Bone Marrow Transplantation. 49(3). 397–402. 46 indexed citations
14.
Garcı́a, Ana Maria, Orville Hernández, Ángel González, et al.. (2009). Presence and expression of the mating type locus in Paracoccidioides brasiliensis isolates. Fungal Genetics and Biology. 47(4). 373–380. 24 indexed citations
15.
Garcı́a, Gissel, Marcos Arango, Ana Beatriz Alvarez Pérez, et al.. (2006). Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. Journal of Clinical Virology. 37(1). 53–57. 30 indexed citations
16.
Tobón, Ángela María, et al.. (2003). Residual Pulmonary Abnormalities in Adult Patients with Chronic Paracoccidioidomycosis: Prolonged Follow-Up after Itraconazole Therapy. Clinical Infectious Diseases. 37(7). 898–904. 66 indexed citations
17.
Sigler, Lynne, et al.. (1998). Maxillary sinusitis caused by Schizophyllum commune and experience with treatment.. PubMed. 35(5). 365–70. 35 indexed citations
18.
Sigler, Lynne, et al.. (1997). Maxillary sinusitis caused bySchizophyllum communeand experience with treatment. Medical Mycology. 35(5). 365–370. 31 indexed citations
19.
Arango, Marcos, et al.. (1997). [The value of immunological assays in the diagnosis of meningeal histoplasmosis].. PubMed. 25(145). 1376–80. 5 indexed citations
20.
Arango, Marcos, et al.. (1982). T-cell dysfunction and hyperimmunoglobulinemia E in paracoccidioidomycosis. Mycopathologia. 79(2). 115–123. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J C Voltarelli Breakdown of academic impact, for papers by Zoe Dorothea Pana Breakdown of academic impact, for papers by Daniel Teschner Breakdown of academic impact, for papers by R.I. Schiff Breakdown of academic impact, for papers by Hisashi FUNADA Breakdown of academic impact, for papers by Martha C. Moreno‐Lafont Breakdown of academic impact, for papers by Elena B. Lugli Breakdown of academic impact, for papers by Amado Saúl Breakdown of academic impact, for papers by Khaled Khoufache Breakdown of academic impact, for papers by Sivan Bercovici
Rankless by CCL
2026